Spots Global Cancer Trial Database for A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Official Title: A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Study ID: NCT01733004
Conditions
Interventions
Study Description
Brief Summary: This study is a Phase 1 and pharmacologic open-labeled dose-escalation trial using a "3+3" design, evaluating MM-141 at varying dose levels and frequencies.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Marietta, Georgia, United States
, Boston, Massachusetts, United States
, Detroit, Michigan, United States
, Villejuif, , France
Contact Details
Name: Chrystal Louis, MD, MPH
Affiliation: Merrimack Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
